Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
12 studies found for:    SCHIZOPHRENIA 11
Show Display Options
Rank Status Study
1 Recruiting Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Conditions: Schizoaffective Disorder;   Schizophrenia
Intervention:
2 Active, not recruiting Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome
Condition: Schizophrenia
Interventions: Other: schizophrenia;   Other: the 22q11 deletion syndrome;   Other: control group
3 Recruiting Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Conditions: Schizophrenia;   Cannabis Dependence;   Prodromal for Psychotic Illness;   Family History of Alcoholism
Intervention: Radiation: [11-C]OMAR
4 Recruiting Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention: Drug: risperidone
5 Completed Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.
Condition: Schizophrenia
Intervention: Drug: GSK1018921
6 Completed A PET Study With RO5545965 in Healthy Male Volunteers
Condition: Schizophrenia
Intervention: Drug: RO5545965
7 Completed First Time in Human Study (FTIH) With Positron Emission Tomography (PET)
Conditions: Schizophrenia;   Healthy Volunteer
Intervention: Drug: GSK1144814
8 Completed A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
Condition: Schizophrenia
Intervention: Procedure: pet/spect scan
9 Completed Cognitive Remediation in 22q11DS
Conditions: 22q11.2 Deletion Syndrome;   Velo-Cardio-Facial Syndrome
Interventions: Behavioral: Cognitive remediation program;   Behavioral: Small group social skills training
10 Completed PET Neuroimaging of [11C]Mirtazapine
Conditions: Mental Disorders;   Mood Disorders;   Affective Disorders;   Depressive Disorders
Intervention: Drug: Mirtazapine
11 Terminated Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
Conditions: Velo-cardio-facial Syndrome;   Psychosis
Interventions: Drug: Metyrosine;   Drug: Placebo
12 Completed Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
Conditions: Healthy Subjects;   Cognitive Disorders
Intervention: Drug: GSK1034702

Indicates status has not been verified in more than two years